Stark C A, Adamsson I, Edlund C, Sjösted S, Seensalu R, Wikström B, Nord C E
Department of Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.
J Antimicrob Chemother. 1996 Dec;38(6):927-39. doi: 10.1093/jac/38.6.927.
Fourteen patients with Helicobacter pylori infection were treated with omeprazole capsules 20 mg and amoxycillin capsules 1000 mg twice daily for 14 days and 14 patients with omeprazole capsules 20 mg and placebo twice daily for 14 days. Samples from saliva, dental plaque and faeces and biopsies from antrum and corpus were analysed in order to determine the ecological changes in the normal microflora. Several microorganisms were affected by both treatment regimens. Two patients were colonised with enterobacteria in the oral cavity and stomach during the omeprazole plus amoxycillin treatment. A general increase in the number of microorganisms from gastric mucosa was observed in both treatment groups. A selection of resistant enterobacteria and an increase in beta-lactamase production was observed in the faecal samples during the omeprazole plus amoxycillin treatment. Eradication of H. pylori in the omeprazole-amoxycillin group was 50% and in the omeprazole placebo group 0% four weeks after treatment. No viable H. pylori were cultivated in the saliva, dental plaque or faecal samples. Treatment with omeprazole 20 mg and amoxycillin 1000 mg twice daily for 14 days altered the normal microflora in the oral, gastric and intestinal tract and antibiotic resistant microorganisms increased in numbers in the intestinal microflora.
14例幽门螺杆菌感染患者接受治疗,服用20毫克奥美拉唑胶囊和1000毫克阿莫西林胶囊,每日两次,共14天;另有14例患者服用20毫克奥美拉唑胶囊和安慰剂,每日两次,共14天。对唾液、牙菌斑和粪便样本以及胃窦和胃体活检组织进行分析,以确定正常微生物群的生态变化。两种治疗方案均对几种微生物产生了影响。在奥美拉唑加阿莫西林治疗期间,有两名患者口腔和胃中出现肠杆菌定植。两个治疗组均观察到胃黏膜微生物数量普遍增加。在奥美拉唑加阿莫西林治疗期间,粪便样本中出现了耐药肠杆菌的选择以及β-内酰胺酶产生增加的情况。治疗四周后,奥美拉唑-阿莫西林组幽门螺杆菌根除率为50%,奥美拉唑-安慰剂组为0%。在唾液、牙菌斑或粪便样本中未培养出存活的幽门螺杆菌。每日两次服用20毫克奥美拉唑和1000毫克阿莫西林,共14天的治疗改变了口腔、胃和肠道中的正常微生物群,肠道微生物群中耐药微生物数量增加。